← Back to headlines
Pfizer's Braftovi Receives Full FDA Approval for Colorectal Cancer
Pfizer announced that its drug Braftovi has received full approval from the FDA for the treatment of colorectal cancer.
24 Feb, 18:26 — 24 Feb, 18:26
Sources
Showing 1 of 1 sources
